PyInvesting

Market research

300723.SHE Yipinhong Pharmaceutical Co.,Ltd

SHE CNY Healthcare

Latest close

27.66 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
14B
P/E ratio
61.78
Analyst target
35.88
Dividend yield
Not available
Beta
0.75

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Yipinhong Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 19.6% above its 200 day moving average.

From a valuation standpoint, the stock is 53.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.

Yipinhong Pharmaceutical Co.,Ltd's total revenue rose by 7.9% to $481M since the same quarter in the previous year.

Its net income has increased by 220.5% to $29M since the same quarter in the previous year.

Finally, its free cash flow grew by 65.1% to $31M since the same quarter in the previous year.

Based on the above factors, Yipinhong Pharmaceutical Co.,Ltd gets an overall score of 5/5.